Restricted Mean Survival Times to Improve Communication of Evidence from Cancer Randomized Trials and Observational Studies.
editorial · Level V
Where this comes from
- Record sourced from PubMed, PMID 31031048.
- Also identified by DOI 10.1016/j.eururo.2019.04.002.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Hazard ratios (HRs) are frequently misinterpreted. We describe an easily estimated complementary measure, the difference in restricted mean survival time (RMST), that requires fewer assumptions than the HR and is more readily interpretable. Reporting RMST-based measures may benefit shared decision-making.
Medical subject headings
- Prostatic Neoplasms
- Research Design